IGF2BP2 and nonpapillary renal cell carcinoma: We first detected the levels of IGF2BP2 in ccRCC tissues compared to those in matched adjacent noncancerous tissues (n = 110) and found that it was significantly downregulated in human ccRCC tissues (Figure 6A).